The Center for Biotechnology at Stony Brook University has established the Biotechnology Commercialization Fund to accelerate the development of promising biomedical technologies emerging from Stony Brook University, according to a university announcement.
Created with support from the New York State Foundation for Science, Technology, and Innovation (NYSTAR) and the Office of the Vice President for Research at Stony Brook University, the Fund will immediately help develop six technologies in partnership with researchers university-wide.
These projects, selected for support by an independent panel of industry and academic advisors, encompass a wide range of technologies with total funding reaching $456,000 for 2011. Overall, the projects center on the discovery of new diagnostics and therapeutics in areas such as musculoskeletal diseases, metabolic and cognitive disorders, cancer, burn injuries, inflammatory diseases, and other medical conditions, according to the announcement.
To read the full, original article click on this link: Stony Brook Center For Biotechnology Launches Commercialization Fund
